Is there a validated clinical prediction score for suspected meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Prediction Scores for Suspected Meningitis

Yes, there are validated clinical prediction scores for suspected meningitis, with the Bacterial Meningitis Score (BMS) being the most extensively validated tool that can safely rule out bacterial meningitis when the score is 0.

The Bacterial Meningitis Score (BMS)

The BMS is a validated clinical prediction rule that identifies patients at very low risk for bacterial meningitis based on five high-risk criteria 1:

  • Positive CSF Gram stain
  • CSF protein ≥80 mg/dL
  • CSF absolute neutrophil count (ANC) ≥1,000 cells/mm³
  • Peripheral blood ANC ≥10,000 cells/mm³
  • Seizure at or prior to presentation

Patients with NONE of these criteria (BMS = 0) are at very low risk for bacterial meningitis.

Performance in Different Populations

In adults: The BMS demonstrates excellent performance with sensitivity of 100% (95% CI: 40-100%), specificity of 51% (95% CI: 46-56%), and negative predictive value of 100% (95% CI: 98-100%) 1. A more recent multicenter study in adults confirmed a negative predictive value of 99.5% (95% CI: 97.4-100) with only one bacterial meningitis case missed among patients with BMS = 0 2.

In children: Multiple validation studies confirm the BMS performs well in pediatric populations aged ≥28 days, with AUCs ranging from 0.74 to 0.96 (median 0.89) 3. However, performance is lower in neonates with AUCs ranging from 0.58 to 0.91 (median 0.79) 3.

Clinical Utility

When applied prospectively, the BMS could reduce hospital admission rates from 84% to 49% without missing bacterial meningitis cases 1. The score showed potential to avoid 64.1% (95% CI: 57.3-70.3) of unnecessary meningeal-dose antibiotic treatments 2.

Alternative Scoring Systems

Meningitis Score for Emergencies (MSE)

This pediatric prediction rule assigns points as follows 4:

  • 3 points: Procalcitonin >1.2 ng/dL
  • 2 points: CSF protein >80 mg/dL
  • 1 point each: CRP >40 mg/L and CSF ANC >1,000 cells/mm³

A score ≥3 showed optimal performance with sensitivity of 92.86% (95% CI: 83.3-100), specificity of 65.22% (95% CI: 51.5-79), and negative predictive value of 93.75% (95% CI: 85.4-100) 4. The AUC was 0.79 (95% CI: 0.681-0.897).

UK-ChiMES Scores

Recent pediatric data from Germany showed the UK-ChiMES pre-lumbar puncture score demonstrated sensitivity of 84.6% and specificity of 86.3%, while the post-lumbar puncture score showed sensitivity of 76.9% and specificity of 92.7% 5.

Enhancing Prediction with Biomarkers

The BMS combined with additional biomarkers can achieve 100% negative predictive value 2:

  • BMS + CSF lactate ≥2 mmol/L: NPV 100% (95% CI: 94.6-100)
  • BMS + blood procalcitonin ≥0.29 µg/L: NPV 97.9% (95% CI: 92.5-99.7)
  • BMS + blood CRP ≥24 mg/L: NPV 98.9% (95% CI: 96.1-99.9)

Important Caveats

These scores should NOT be used to determine whether to initiate antimicrobial therapy in individual patients 6. The 2004 Infectious Diseases Society of America guidelines emphasize that clinical judgment remains paramount 6.

Key pitfall: While prediction scores show high negative predictive values, they are screening tools to support—not replace—clinical assessment. When bacterial meningitis is suspected based on clinical presentation (altered consciousness, immunocompromise, CNS disease history, new seizure, papilledema, focal neurologic deficits), empirical antibiotics should be administered immediately after obtaining blood cultures and CSF, regardless of score 6.

The BMS performs less reliably in neonates and should be applied cautiously in this population 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.